Fixkoh Airmaster is indicated in the regular treatment of asthma where use of a combination product (long-acting β2-agonist and inhaled corticosteroid) is appropriate:^5,6,7

• Patients not adequately controlled with inhaled corticosteroids and ‘as needed’ inhaled short-acting β2-agonist^5,6,7
• Patients already adequately controlled on both inhaled corticosteroid and long-acting β2-agonist^5,6,7

for the symptomatic treatment of patients with COPD, with a  FEV1 < 60 % predicted normal (pre-bronchodilator) and a history of repeated exacerbations, who have significant symptoms despite regular bronchodilator therapy^5,6,7

Fixkoh Airmaster dosing information:

• The recommended dose of Fixkoh Airmaster  50/100mcg, 50/250mcg or 50/500mcg is one inhalation, twice daily.^5,6,7
• Fixkoh Airmaster comes in three different doses, allowing flexibility of dosing for your patients with asthma at low, medium and high dose inhaled corticosteroid (ICS).^5,6,7
• Fixkoh Airmaster 50/500mcg suitable for use for your patients with COPD.^5,6,7
• Fixkoh Airmaster is indicated in adults and adolescents 12 years of age and older.^5,6,7

Fixkoh Airmaster pricing information:

• Low Dose (50/100mcg): £14.47 (£2.99 or 17% more cost-effective than Seretide 100 Accuhaler)¹
• Medium Dose (50/250mcg): £19.29 (£14.66 or 43% more cost-effective than Seretide 250 Accuhaler)¹
• High Dose (50/500mcg): £16.12 (£16.62 or 51% more cost-effective than Seretide 500 Accuhaler)*